There's nothing generic about this drugmaker's recent performance and continued prospects.

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

In the current market session, Teva Pharmaceutical Indus Inc. (NYSE:TEVA) stock price is at $34.97, after a 2.32% drop. However, over the past month, the company's stock went up by 5.42%, and in the ...

These three high-quality stocks have ample growth potential.

Investors in Teva Pharmaceutical Industries Ltd (Symbol: TEVA) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Prague-based Pale Fire Capital SE added 639,162 shares of Teva in the third quarter. The overall position value increased by $16.53 million from the previous period. As of September 30, the fund ...

The generic drugs that Teva makes normally sell for materially less than the name-brand versions. While that leads to a steep decline in revenue for each company that originally created a now-generic ...

Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and specialty medications. ANIP’s operations are split between rare disease ...